198 filings
Page 3 of 10
8-K
zjfiprq3
3 Aug 17
Bioamber Announces Record Revenues for the Second Quarter 2017 and Purchase of Mitsui Equity Stake In Sarnia Joint Venture
12:00am
8-K
c86fhxht
15 May 17
BioAmber Announces Changes to its Board of Directors, the Appointment of a
12:00am
8-K
tl746
9 May 17
BioAmber Reports First Quarter 2017 Financial Results
12:00am
25-NSE
t4ng d50pm
5 May 17
Exchange delisting
12:00am
8-K
x9m 08dmv1jrhs47q7p
4 May 17
Other Events
12:00am
CT ORDER
i8s8a0lw
4 Apr 17
Confidential treatment order
12:00am
8-K
3riyawmi7o 5i5a4uy
31 Mar 17
BioAmber Announces CFO Transition
12:00am
DEFA14A
zgt30
31 Mar 17
Additional proxy soliciting materials
12:00am
8-K
p9n5n27 e5tcqgrjn416
16 Mar 17
BioAmber Announces Year End Operational and Financial Results for 2016
12:00am
8-K
qjgz39s vkt3j4uytf
21 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
k0ahqkoy fsmaxt0ti
30 Jan 17
Termination of a Material Definitive Agreement
12:00am
8-K
u0d2wpe
27 Jan 17
Bioamber Inc. Increases Previously Announced Public Offering to US$17.5 Million
12:00am
FWP
f9bda57lzpniwtgb59q
24 Jan 17
Free writing prospectus
12:00am
424B5
2fiu9e0mjyqqrmvnz l2
24 Jan 17
Prospectus supplement for primary offering
12:00am
8-K
xcfxf
23 Jan 17
Bioamber Inc. Announces US$10 Million Underwritten Public Offering
12:00am
FWP
v2zn99ofu3zkjui
23 Jan 17
Free writing prospectus
12:00am
424B5
sdulyreg0ogc
23 Jan 17
Prospectus supplement for primary offering
12:00am